References
- Kufe D W, Spriggs D, Egan M, Munroe D. Relationships among ara-CTP pools, formation of (ara-C) DNA and cytotoxicity of human leukemic cells. Blood 1984; 64: 54–61
- Kufe D W, Munroe D, Herrick D, et al. Effects of 1-β-D-arabinofuranosylcytosine incorporation on eukryotic DNA template function. Molec Pharmacol 1984; 26: 128–134
- Shimada N, Ueda T, Yokoshima T, et al. A sensitive and specific radioimmunoassay for 1-β-D-arabinofuranosylcytosine. Cancer Letters 1984; 24: 173–178
- Kawasaki H, Ohkubo T, Nobori T, et al. Analysis of intracellular deoxyribonucleic acid pool using HPLC equipped with DEAE-2SW column. Igaku No Ayumi 1986; 137: 1019–1020
- Khym JX. An analytical system for rapid separation of tissue nucleotides at low pressure on conventional anion exchangers. Clin Chem 1975; 21: 124–134
- Pogolotti A L, Santi DV. High-pressure liquid chromatography-ultraviolet analysis of intracellular nucleotides. Anal Biochem 1982; 126: 335–342
- Higashigawa M, Ookubo T, Ochiai H, Kawasaki H, Sakurai M. Incorporation of N4-behenoyl-1-β-D-arabinofuranosylcytosine into DNA as 1-β-D-arabinofuranosylcytosine. Med Oncol Tumor Phamacother 1989; 5: 265–271
- Ohkubo T. Biochemical modulation of 5-fluorouracil and cytosine arabinoside by sequential administration of methotrexate. Mie Med J 1985; 35: 155–162
- Kawasaki H, Nobori T, Kamiya H, Sakurai M. Biochemical modulation in cancer chemotherapy. Jpn J Cancer Chemother 1985; 12: 815–821
- Nobori T, Ochiai H, Shimizu N, Kawasaki H. Enhanced production of intracellular ara-CTP after sequential use of methotrexate and 1-β-D-arabinofuranosylcytosine. Leukemia Res 1985; 9: 1263–1268
- Bertino JR. Clinical use of methotrexate with emphasis on use of high doses. Cancer Treat Rep 1981; 65: 131–138
- Avery T L, Robert D. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210. Eur J Cancer 1974; 10: 425–432
- Kawasaki H, Ohkubo T, Nobori T, et al. The effect of methotrexate on intracellular nucleotide pools. Jpn J Cancer Chemother 1985; 12: 815–819
- Nobori T, Ochiai H, Shimizu N, Kawasaki H. Effects of methotrexate on the intracellular nucleotide pools and its role, in combination chemotherapy. Purine and Purine Metabolism in Man V, WL Nyhan, LF Thompson, RWE. Watts. Plenum Publishing, New York 1986
- Jackson R C, Harkrader RJ. Synergistic and antagonistic interactions of methotrexate and 1-β-D-arabinofuranosylcytosine in hepatoma cells. Biochem Pharmacol 1981; 30: 223–243
- Cadman E, Eifeman F. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside. J Clin Invest 1981; 64: 788–793
- Nobori T, Kamiya H. Mechanism of resistance to anticancer drugs and trials to overcome their resistance. Jpn J Clin Hematol 1986; 27: 1460–1464
- Liliemark J O, Plumkett W. Regulation of 1-β-D-arabinofuranosylcytosin accumulation in human leukemic cells by deoxycytidine-5'-triphosphates. Cancer Res 1986; 46: 1079–1085